Consumer Health in Lithuania
Consumer health sales in Lithuania are resettling in 2024 following fluctuations during and following the COVID-19 pandemic. Overall, sales are generally fairly stagnant with declines in some segments – largely due to a stabilised consumer base following a temporary boost by migration from Ukraine and other countries.
Euromonitor International's Consumer Health in Lithuania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Consumer Health in Lithuania
- Euromonitor International
- October 2024
- List Of Contents And Tables
- CONSUMER HEALTH IN LITHUANIA
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 2 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 3 Sales of Consumer Health by Category: Value 2019-2024
- Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 7 Penetration of Private Label by Category: % Value 2019-2024
- Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
- ANALGESICS IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Robust rises in 2024 although mainly due to price hikes
- Marketing and promotions attract consumers as category remains led by international players
- Solpadine suffers supply issues
- PROSPECTS AND OPPORTUNITIES
- Category growth looks set to be solid
- Ibuprofen will maintain stronghold as overall category lacks innovation
- Naproxen holds potential for expansion, while modern grocery retailers expand
- CATEGORY DATA
- Table 12 Sales of Analgesics by Category: Value 2019-2024
- Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- 2024 sees little change
- Low flu incidence undermines overall demand
- Non-drowsy Opexa marches onwards
- PROSPECTS AND OPPORTUNITIES
- Moderate growth predicated for forecast period
- Lack of innovation to persist, while decongest sprays gather further ground
- Climate change continues to push up incidence of allergies
- CATEGORY DATA
- Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
- Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
- Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
- Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
- Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
- Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
- DIGESTIVE REMEDIES IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Value growth driven by rising prices
- A Menarini Industrie Farmaceutiche Riunite maintains overall leadership
- Dosages increase as consumers seek sure results though volume sales remain limited by lack of significant innovation
- PROSPECTS AND OPPORTUNITIES
- Low but stable sales across category
- Widespread reflux will support antacids, and ageing population will drive value growth
- Limited local presence in competitive landscape
- CATEGORY DATA
- Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
- Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
- Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
- Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
- Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
- Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
- DERMATOLOGICALS IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Convincing performance from dermatologicals in 2024
- Female-oriented products and topical antifungals gain ground
- Multinationals continue to lead, leaving little space for local players
- PROSPECTS AND OPPORTUNITIES
- Little change anticipated for dermatologicals
- Cold sore treatments will continue to expand but vaginal antifungals has reached its peak
- Out-of-home habits to support topical antiseptics while hair loss sales will benefit from innovation
- CATEGORY DATA
- Table 30 Sales of Dermatologicals by Category: Value 2019-2024
- Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
- Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
- Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
- Table 34 Forecast Sales of Dermatologicals by Category: Value 2024-2029
- Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
- WOUND CARE IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Early summer bodes well for wound care
- Sticking plasters/adhesive still largest subcategory
- Private label expands within landscape led by multinationals.
- PROSPECTS AND OPPORTUNITIES
- Volume sales likely to stagnate
- Private label will continue to steal share
- Niche and premium products may rise slightly
- CATEGORY DATA
- Table 36 Sales of Wound Care by Category: Value 2019-2024
- Table 37 Sales of Wound Care by Category: % Value Growth 2019-2024
- Table 38 NBO Company Shares of Wound Care: % Value 2020-2024
- Table 39 LBN Brand Shares of Wound Care: % Value 2021-2024
- Table 40 Forecast Sales of Wound Care by Category: Value 2024-2029
- Table 41 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
- VITAMINS IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Volume growth declines in 2024
- Vitamin B rises as D falls
- Valentis maintains leadership label remains strong
- PROSPECTS AND OPPORTUNITIES
- Moderate forecast period facing vitamins in Lithuania
- Multivitamins will continue to be popular
- Single vitamins face varied fortunes while multivitamins will see greater specificity
- CATEGORY DATA
- Table 42 Sales of Vitamins by Category: Value 2019-2024
- Table 43 Sales of Vitamins by Category: % Value Growth 2019-2024
- Table 44 Sales of Multivitamins by Positioning: % Value 2019-2024
- Table 45 NBO Company Shares of Vitamins: % Value 2020-2024
- Table 46 LBN Brand Shares of Vitamins: % Value 2021-2024
- Table 47 Forecast Sales of Vitamins by Category: Value 2024-2029
- Table 48 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
- DIETARY SUPPLEMENTS IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Stable growth for dietary supplements
- Fish oils goes from strength to strength and eye health sees further expansion
- Direct selling remains relevant in a fragmented landscape
- PROSPECTS AND OPPORTUNITIES
- Only low growth predicted for dietary supplements
- Private label will benefit from currently small presence within category
- Combination products to see rising demand, while joint health holds potential
- CATEGORY DATA
- Table 49 Sales of Dietary Supplements by Category: Value 2019-2024
- Table 50 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
- Table 51 Sales of Dietary Supplements by Positioning: % Value 2019-2024
- Table 52 NBO Company Shares of Dietary Supplements: % Value 2020-2024
- Table 53 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
- Table 54 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
- Table 55 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
- WEIGHT MANAGEMENT AND WELLBEING IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Decline for weight loss supplements continues into 2024
- Direct selling offers sports nutrition to boost sales
- Ozempic usage grows while slimming teas gains ground
- PROSPECTS AND OPPORTUNITIES
- Decline for weight loss supplements shows no sign of reversal
- Direct selling to remain primary distribution channel
- Slimming teas to see positive but low volume growth as consumers shift to healthier options
- CATEGORY DATA
- Table 56 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
- Table 57 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
- Table 58 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
- Table 59 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
- Table 60 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
- Table 61 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
- SPORTS NUTRITION IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Sports nutrition makes further gains in 2024
- Sports protein-based products keep on rising
- E-commerce is major channel for sports nutrition sales
- PROSPECTS AND OPPORTUNITIES
- Bright future anticipated for sports nutrition
- Local players will maintain market presence amid expanding retail presence
- Protein bars contain high potential, with e-commerce further strengthening its commanding lead in distribution
- CATEGORY DATA
- Table 62 Sales of Sports Nutrition by Category: Value 2019-2024
- Table 63 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
- Table 64 NBO Company Shares of Sports Nutrition: % Value 2020-2024
- Table 65 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
- Table 66 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
- Table 67 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
- HERBAL/TRADITIONAL PRODUCTS IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Moderate growth posted in 2024
- Eucarbon Herbal leads herbal digestive remedies brands, while Sinupret maintains overall category lead
- Local player Valentis gains value share in 2024
- PROSPECTS AND OPPORTUNITIES
- Low growth ahead for herbal/traditional products in Lithuania
- Sleep aids likely to see volume rises while Valentis benefits from strong reputation for paediatric solutions
- Haemorrhoid treatments to maintain presence in herbal dermatologicals, and environmental focus could expand consumer base
- CATEGORY DATA
- Table 68 Sales of Herbal/Traditional Products: Value 2019-2024
- Table 69 Sales of Herbal/Traditional Products: % Value Growth 2019-2024
- Table 70 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
- Table 71 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
- Table 72 Forecast Sales of Herbal/Traditional Products: Value 2024-2029
- Table 73 Forecast Sales of Herbal/Traditional Products: % Value Growth 2024-2029
- PAEDIATRIC CONSUMER HEALTH IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Post-pandemic surge settles down
- Ibuprofen still preferred product, with fish oil also popular
- Continued shift towards products with a natural positioning
- PROSPECTS AND OPPORTUNITIES
- Moderate growth predicted for overall category
- Vitamins and dietary supplements set to do well
- No sign of new challengers
- CATEGORY DATA
- Table 74 Sales of Paediatric Consumer Health by Category: Value 2019-2024
- Table 75 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
- Table 76 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
- Table 77 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook